The ice pack test — a simple procedure in which a bag filled with ice is placed over the eyelids…
Articles by Joana Carvalho, PhD
Catalyst Pharmaceuticals and KYE Pharmaceuticals have reached an exclusive agreement that will enable KYE to commercialize…
A post-exercise facilitation test, which measures muscle activity following voluntary muscle contraction or electrical stimulation, can help identify the effects…
A new scoring tool can be used to effectively estimate the risk of developing small cell lung cancer (SCLC)…
People with Lambert-Eaton myasthenia syndrome (LEMS) have a specific response pattern to repetitive nerve stimulation — known as…
Despite the COVID-19 pandemic, Catalyst Pharmaceuticals is still expecting Firdapse (amifampridine) to be approved for the treatment of…
A group of experts have provided a series of recommendations for people with myasthenia gravis (MG) and Lambert-Eaton…
Patients with Lambert-Eaton myasthenic syndrome (LEMS) live as long as people who do not have the disease, and can…
Treatment with Firdapse (Amifampridine phosphate) or Ruzurgi (3,4‐diaminopyridine, or 3,4‐DAP) is effective and well-tolerated among people…
3,4‐diaminopyridine — the active ingredient of the only FDA-approved treatment for adults with Lambert-Eaton myasthenic syndrome (LEMS) —…